GRAIL, акция обыкновенная (US3847471014, GRAL, NL0, GRAL.P)

GRAIL, Inc. operates as a biotechnology company. The Company focuses on combining science, technology, and clinical studies to reveal cancer at its beginings. GRAIL offers its services in the United States.

• Выручка
• Чистая прибыль
• EBITDA
• Активы
• Капитал
• Рентабельность по EBITDA (%)
• Чистый долг / EBITDA
• Общий долг / Капитал